Article révisé par les pairs
Titre:
  • The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
Auteur:El Bairi, Khalid; Haynes, Harry R; Blackley, Elizabeth EF; Fineberg, Susan; Shear, Jeffrey; Turner, Sophia; de Freitas, Juliana Ribeiro; Sur, Daniel; Amendola, Luis Claudio; Gharib, Masoumeh; Kallala, Amine; Arun, Indu; Azmoudeh-Ardalan, Farid; Fujimoto, Luciana; Sua, Luz F; Liu, Shi-Wei; Lien, Huang-Chun; Kirtani, Pawan; Balancin, Marcelo; El Attar, Hicham; Guleria, Prerna; Yang, Wenxian; Shash, Emad; Chen, I-Chun; Bautista, Veronica; Do Prado Moura, Jose Fernando; Rapoport, Bernardo Leon B.; Castaneda, Carlos; Spengler, Eunice; Acosta-Haab, Gabriela; Frahm, Isabel; Sanchez, Joselyn; Castillo, Miluska; Bouchmaa, Najat; Md Zin, Reena RR; Shui, Ruohong; Onyuma, Timothy; Yang, Wentao; Husain, Zaheed; Willard-Gallo, Karen; Coosemans, Alphonse; Perez, Edith A; Provenzano, Elena; Ericsson, Paula Gonzalez; Richardet, Eduardo; Mehrotra, Ravi; Sarancone, Sandra; Ehinger, Anna; Rimm, David L; Bartlett, John M S; Viale, Giuseppe; Denkert, Carsten; Hida, Akira I; Sotiriou, Christos; Loibl, Sibylle; Hewitt, Stephen M; Badve, Sunil; Symmans, William Fraser; Kim, Seong-Rim; Pruneri, Giancarlo; Goel, Shom; Francis, Prudence A; Inurrigarro, Gloria; Yamaguchi, Rin; Garcia-Rivello, Hernan; Horlings, Hugo Mark; Afqir, Said; Salgado, Roberto; Adams, Sylvia; Kok, Marleen; Dieci, Maria Vittoria; Michiels, Stefan; Demaria, Sandra; Loi, Sherene; International Immuno-Oncology Biomarker Working Group,
Informations sur la publication:NPJ breast cancer, 7, 1, page (150)
Statut de publication:Publié, 2021-12-01
Sujet CREF:Sciences bio-médicales et agricoles
Langue:Anglais
Identificateurs:urn:issn:2374-4677
info:doi/10.1038/s41523-021-00346-1
info:pii/10.1038/s41523-021-00346-1
info:pmid/34853355
PMC8636568

Documents en relation

DI-fusion

  • Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer
    par Loi, Sherene , Salgado, Roberto , Adams, Sylvia , Pruneri, Giancarlo , Francis, Prudence P.A. , Lacroix-Triki, Magali , Joensuu, Heikki , Dieci, Maria Vittoria , Badve, Sunil , Demaria, Sandra , Gray, Robert , Munzone, Elisabetta , Drubay, Damien , Lemonnier, Jerome , Sotiriou, Christos , Kellokumpu-Lehtinen, Pirkko-Liisa , Vingiani, Andrea , Gray, Kathryn , Andre, Fabrice , Denkert, Carsten , Piccart-Gebhart, Martine , Roblin, Elvire , Michiels, Stefan
    Publication 2022-12
  • Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials.
    par Hudeček, Jan , Voorwerk, Leonie , van Seijen, Maartje , Nederlof, Iris , de Maaker, Michiel , van den Berg, Jose , van de Vijver, Koen K , Sikorska, Karolina , Adams, Sylvia , Demaria, Sandra , Viale, Giuseppe , Nielsen, Torsten O , Badve, Sunil , Michiels, Stefan , Symmans, William Fraser , Sotiriou, Christos , Rimm, David L , Hewitt, Stephen M , Denkert, Carsten , Loibl, Sibylle , Loi, Sherene , Bartlett, John M S , Pruneri, Giancarlo , Dillon, Deborah A , Cheang, Maggie C U , Tutt, Andrew M , Hall, Jacqueline Anne , Kos, Zuzana , Salgado, Roberto , Kok, Marleen , Horlings, Hugo Mark , International Immuno-Oncology Biomarker Working Group
    Publication 2020-01-01
  • The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.
    par Gonzalez-Ericsson, Paula I , Stovgaard, Elisabeth ES , Sua, Luz F , Reisenbichler, Emily , Kos, Zuzana , Carter, Jodi M , Michiels, Stefan , Le Quesne, John , Nielsen, Torsten O , Laenkholm, Anne-Vibeke , Fox, Stephen B , Adam, Julien , Bartlett, John Ms , Rimm, David L , Quinn, Cecily , Peeters, Dieter , Dieci, Maria V , Vincent-Salomon, Anne , Cree, Ian , Hida, Akira I , Balko, Justin M , Haynes, Harry HR , Frahm, Isabel , Acosta-Haab, Gabriela , Balancin, Marcelo , Bellolio, Enrique , Yang, Wentao , Kirtani, Pawan , Sugie, Tomoharu , Ehinger, Anna , Castaneda, Carlos Altamirano , Kok, Marleen , McArthur, Heather , Siziopikou, Kalliopi , Badve, Sunil , Fineberg, Susan , Gown, Allen A.M. , Viale, Giuseppe , Schnitt, Stuart J , Pruneri, Giancarlo , Penault-Llorca, Frederique , Hewitt, Stephen M , Thompson, E Aubrey , Allison, Kimberly H , Symmans, William Fraser , Bellizzi, Andrew M , Brogi, Edi , Moore, David A , Larsimont, Denis , Dillon, Deborah A , Lazar, Alexander , Lien, Huangchun , Goetz, Matthew P , Broeckx, Glenn , El Bairi, Khalid , Harbeck, Nadia , Cimino-Mathews, Ashley , Sotiriou, Christos , Adams, Sylvia , Liu, Shi-Wei , Loibl, Sibylle , Chen, I-Chun , Lakhani, Sunil R , Juco, Jonathan W , Denkert, Carsten , Blackley, Elizabeth EF , Demaria, Sandra , Leon-Ferre, Roberto , Gluz, Oleg , Zardavas, Dimitrios , Emancipator, Kenneth , Ely, Scott , Loi, Sherene , Salgado, Roberto , Sanders, Melinda M.E. , International Immuno-Oncology Biomarker Working Group
    Publication 2020-03-01
  • Differential benefit of metronomic chemotherapy among triple negative breast cancer subtypes treated in the IBCSG Trial 22-00.
    par Joaquin Garcia, Andrea , Rediti, Mattia , Venet, David , Majjaj, Samira , Kammler, Roswitha , Munzone, Elisabetta , Gianni, Lorenzo , Thürlimann, Beat , Láng, I , Colleoni, Marco Angelo , Loi, Sherene , Viale, Giuseppe , Regan, Meredith M , Buisseret, Laurence , Rothé, Françoise , Sotiriou, Christos
    Publication 2023-09-01
  • Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials.
    par Rediti, Mattia , Fernandez-Martinez, Aranzazu , Venet, David , Rothé, Françoise , Hoadley, Katherine A , Parker, Joel S , Singh, Baljit , Campbell, Jordan D , Ballman, Karla V , Hillman, David W , Winer, Eric P , El-Abed, Sarra , Piccart, Martine , Di Cosimo, Serena , Symmans, William Fraser , Krop, Ian , Salgado, Roberto , Loi, Sherene , Pusztai, Lajos , Perou, Charles M , Carey, Lisa A , Sotiriou, Christos
    Publication 2023-11